Astex Pharmaceuticals, Inc (ASTX) [Rocket]

Date Filed	Type	Description
07/22/2011	BW	SuperGen to Announce 2011 Second Quarter Financial Results on August 3, 2011
07/20/2011	BW	SuperGen Completes Acquisition of Astex Therapeutics
06/28/2011	BW	SuperGen President & CEO Elected to BIO Board of Directors
06/06/2011	PRN	SuperGen, Inc. Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
06/06/2011	BW	Eisai and Janssen Announce the Presentation of DACOGEN® (decitabine) Data at ASCO from a Phase III Study in Patients with Acute Myeloid Leukemia
05/26/2011	PRN	SuperGen, Inc. to Present Live, Online at RetailInvestorConferences.com on June 2nd
05/16/2011	BW	SuperGen to Present at BioEquity Europe on May 23rd & 24th
05/10/2011	BW	SuperGen to Present at Noble Financial Capital Markets Equity Conference on May 17th
04/27/2011	BW	SuperGen Reports 2011 First Quarter Financial Results
04/20/2011	BW	SuperGen to Announce 2011 First Quarter Financial Results on April 27, 2011
04/08/2011	BW	SuperGen to Present at Future Leaders in the Biotech Industry on April 15th
04/06/2011	BW	SuperGen and Astex Therapeutics Enter Definitive Merger Agreement
03/31/2011	BW	SuperGen to Webcast 5th Annual Investor & Analyst Day on April 12, 2011
03/08/2011	BW	SuperGen to Present at ROTH Annual OC Growth Stock Conference on March 14th
02/28/2011	BW	SuperGen Reports 2010 Fourth Quarter and Year-End Financial Results
02/22/2011	BW	SuperGen to Announce 2010 Fourth Quarter and Year-End Financial Results on February 28, 2011
12/03/2010	BW	SuperGen Announces Presentation of SGI-110 Preclinical Data at American Society of Hematology
11/23/2010	BW	SuperGen to Present at New York Society of Security Analysts' Biotech & Specialty Pharmaceuticals Conference on November 30th
11/15/2010	BW	SuperGen Pipeline Presentations at EORTC-NCI-AACR
11/10/2010	BW	SuperGen Discontinues Clinical Development of SGI-1776
11/09/2010	BW	SuperGen to Present at Lazard Healthcare Conference on November 16th
10/25/2010	BW	SuperGen Reports 2010 Third Quarter Financial Results
10/18/2010	BW	SuperGen to Announce 2010 Third Quarter Financial Results on October 25, 2010
09/28/2010	BW	SuperGen to Present at BIO Investor Forum on October 5th
09/15/2010	BW	SuperGen to Present at UBS Global Life Sciences Conference on September 22nd
07/26/2010	BW	SuperGen to Announce 2010 Second Quarter Financial Results on August 2, 2010
06/30/2010	BW	Dacogen® (Decitabine) for Injection Phase III AML Results Announced
05/11/2010	BW	SuperGen to Present at Rodman & Renshaw Global Healthcare Conference on May 18th
04/26/2010	BW	SuperGen Reports 2010 First Quarter Financial Results